17.05.2023 10:30:33
|
EQS-AFR: BRAIN Biotech AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: BRAIN Biotech AG
/ Preliminary announcement on the disclosure of financial statements
BRAIN Biotech AG hereby announces that the following financial reports shall be disclosed: Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: May 25, 2023 Address: https://www.brain-biotech.com/de/investoren/finanzpublikationen/2022-23 Language: English Date of disclosure: May 25, 2023 Address: https://www.brain-biotech.com/investors/financial-publications/2022-23
17.05.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | BRAIN Biotech AG |
Darmstädter Straße 34-36 | |
64673 Zwingenberg | |
Germany | |
Internet: | www.brain-biotech.com |
End of News | EQS News Service |
|
1635241 17.05.2023 CET/CEST
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BRAIN Biotech AGmehr Nachrichten
Analysen zu BRAIN Biotech AGmehr Analysen
Aktien in diesem Artikel
BRAIN Biotech AG | 3,47 | -2,25% |